Global Tissue-Based Diagnostics Market Research Report 2024

Publication ID:

PB506246512

Publication Date:

June 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global Tissue-Based Diagnostics market was valued at US$ 5321 million in 2023 and is anticipated to reach US$ 8054.2 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tissue-Based Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue-Based Diagnostics.
Report Scope
The Tissue-Based Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tissue-Based Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tissue-Based Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Danaher
Thermo Fisher Scientific
Abbott
Agilent Technologies
ABCAM
Merck
BD
Hologic
Bio Rad
Segment by Type
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Digital Pathology and Workflow Management
Special Staining
Segment by Application
Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tissue-Based Diagnostics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tissue-Based Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunohistochemistry (IHC)
1.2.3 In Situ Hybridization (ISH)
1.2.4 Digital Pathology and Workflow Management
1.2.5 Special Staining
1.3 Market by Application
1.3.1 Global Tissue-Based Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Research Laboratories
1.3.4 Pharmaceutical Companies
1.3.5 Contract Research Organizations
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tissue-Based Diagnostics Market Perspective (2019-2030)
2.2 Tissue-Based Diagnostics Growth Trends by Region
2.2.1 Global Tissue-Based Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tissue-Based Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Tissue-Based Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Tissue-Based Diagnostics Market Dynamics
2.3.1 Tissue-Based Diagnostics Industry Trends
2.3.2 Tissue-Based Diagnostics Market Drivers
2.3.3 Tissue-Based Diagnostics Market Challenges
2.3.4 Tissue-Based Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tissue-Based Diagnostics Players by Revenue
3.1.1 Global Top Tissue-Based Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Tissue-Based Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Tissue-Based Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tissue-Based Diagnostics Revenue
3.4 Global Tissue-Based Diagnostics Market Concentration Ratio
3.4.1 Global Tissue-Based Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tissue-Based Diagnostics Revenue in 2023
3.5 Tissue-Based Diagnostics Key Players Head office and Area Served
3.6 Key Players Tissue-Based Diagnostics Product Solution and Service
3.7 Date of Enter into Tissue-Based Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tissue-Based Diagnostics Breakdown Data by Type
4.1 Global Tissue-Based Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Tissue-Based Diagnostics Forecasted Market Size by Type (2025-2030)
5 Tissue-Based Diagnostics Breakdown Data by Application
5.1 Global Tissue-Based Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Tissue-Based Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tissue-Based Diagnostics Market Size (2019-2030)
6.2 North America Tissue-Based Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tissue-Based Diagnostics Market Size by Country (2019-2024)
6.4 North America Tissue-Based Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tissue-Based Diagnostics Market Size (2019-2030)
7.2 Europe Tissue-Based Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tissue-Based Diagnostics Market Size by Country (2019-2024)
7.4 Europe Tissue-Based Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tissue-Based Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Tissue-Based Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tissue-Based Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Tissue-Based Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tissue-Based Diagnostics Market Size (2019-2030)
9.2 Latin America Tissue-Based Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tissue-Based Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Tissue-Based Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tissue-Based Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Tissue-Based Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tissue-Based Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Tissue-Based Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Tissue-Based Diagnostics Introduction
11.1.4 Roche Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Tissue-Based Diagnostics Introduction
11.2.4 Danaher Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Tissue-Based Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Tissue-Based Diagnostics Introduction
11.4.4 Abbott Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.4.5 Abbott Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Tissue-Based Diagnostics Introduction
11.5.4 Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.5.5 Agilent Technologies Recent Development
11.6 ABCAM
11.6.1 ABCAM Company Detail
11.6.2 ABCAM Business Overview
11.6.3 ABCAM Tissue-Based Diagnostics Introduction
11.6.4 ABCAM Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.6.5 ABCAM Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Tissue-Based Diagnostics Introduction
11.7.4 Merck Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.7.5 Merck Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Tissue-Based Diagnostics Introduction
11.8.4 BD Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.8.5 BD Recent Development
11.9 Hologic
11.9.1 Hologic Company Detail
11.9.2 Hologic Business Overview
11.9.3 Hologic Tissue-Based Diagnostics Introduction
11.9.4 Hologic Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.9.5 Hologic Recent Development
11.10 Bio Rad
11.10.1 Bio Rad Company Detail
11.10.2 Bio Rad Business Overview
11.10.3 Bio Rad Tissue-Based Diagnostics Introduction
11.10.4 Bio Rad Revenue in Tissue-Based Diagnostics Business (2019-2024)
11.10.5 Bio Rad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Roche
Danaher
Thermo Fisher Scientific
Abbott
Agilent Technologies
ABCAM
Merck
BD
Hologic
Bio Rad

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂